Skip to content

Clinical study on the treatment of meibomian gland dysfunction related dry eye with the intense pulsed light dry eye therapy instrument

Clinical study on the treatment of meibomian gland dysfunction related dry eye with the intense pulsed light dry eye therapy instrument

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045886
Enrollment
Unknown
Registered
2021-04-26
Start date
2015-08-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

meibomian gland dysfunction related dry eye

Interventions

Experimental group:Intense light pulse therapy
positive control group:Hot compress with massage

Sponsors

The Second Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 80 years; 2.According to the diagnostic criteria of "eyelid gland dysfunction and dry eye" in the "expert consensus on clinical diagnosis and treatment of dry eye" formulated by Ophthalmology Society of Chinese Medical Association; 3.Lower lacrimal river height > 0.1mm, meibomian gland obstruction level 1~2; 4.Monocular or binocular lesions; 5.Informed consent and signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Acute ocular surface inflammation and ocular trauma; 2.Steroidal and non-steroidal anti-inflammatory drugs and immunosuppressants are being used; 3.Participate in other medical device trials or drug clinical trials within three months; 4.Women with severe organic diseases, malignant tumors, pregnancy or childbirth; 5.Poor compliance and incomplete information.

Design outcomes

Primary

MeasureTime frame
eye redness;the number of meibomian glands;tear film rupture time;corneal fluorescence staining;

Secondary

MeasureTime frame
lacrimal river height measurement;Palpebral margin morphology;Color and structure of lipid layer;Distribution of lipid layer;Thickness of lipid layer;Quality of meibomian gland;Schirmer test;

Countries

China

Contacts

Public ContactWu Yaohong

Ophthalmology Department of the Second Hospital of Shanxi Medical University

wuyaohong123@163.com+86 13073560193

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026